Search

Your search keyword '"Villaume MT"' showing total 1 results
Start Over Author "Villaume MT" Publisher elsevier

Refine your results

1 results on '"Villaume MT"'

1. Establishing specific response criteria for MDS/MPN - Getting closer to reality?

Author

Villaume MT and Savona MR

Subjects
Humans, Hematologic Neoplasms classification, Hematologic Neoplasms diagnosis, Hematologic Neoplasms therapy, Myelodysplastic Syndromes classification, Myelodysplastic Syndromes diagnosis, Myelodysplastic Syndromes therapy, Myeloproliferative Disorders classification, Myeloproliferative Disorders diagnosis, Myeloproliferative Disorders therapy
Abstract

Competing Interests: Declaration of competing interest MV has no disclosures. MS receives research funding from Astex, Incyte, Takeda and TG Therapeutics; consults and serves as advisory for BMS, Celgene, Karyopharm, Ryvu, Sierra Oncology, Takeda, TG Therapeutics; and has equity in Karyopharm.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results